Inventor

CLARY LAURENCE

FR37 patents

⚠️ This page may combine multiple inventors who share the name “CLARY LAURENCE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CLARY LAURENCE

GALDERMA RES & DEV

Biaromatic ligand activators of PPARγ receptors

Biaromatic compound activators of PPARγ-type receptors

Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics

Biaromatic ligand activators of PPARγ receptors

Biaromatic ligand activators of PPARγ receptors

Compounds that modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof

Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof

Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof

Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof

Biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies

Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics

Biaromatic compound activators of PPARγ receptors and cosmetic/pharmaceutical compositions comprised thereof

MTOR inhibitor compounds

Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof

Methods of modulating PPAR gamma-type receptors

Methods for activating PPAR gamma-type receptors

Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compounds

Biaromatic compounds which activate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprised thereof

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases

Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases

Substituted pyrazolo[3,4-d]pyrimidines as mTOR inhibitors

3-phenylpropanoic compound activators of receptors of PPAR type and pharmaceutical/cosmetic compositions comprised thereof

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases

Biaromatic compounds that modulate PPAR-receptors

Heterocyclic compounds and use thereof in medicine and in cosmetics

Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof

CLARY LAURENCE

Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics

Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics

4-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseases

BOITEAU JEAN-GUY

Biaromatic compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof

3-phenyl acrylic acid compound activators of type PPAR receptors and pharmaceutical/cosmetic compositions comprised thereof

Biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof

CHAMBON SANDRINE

N-[2-hydroxycarbamoyl-2-(piperazinyl) ethyl] benzamide compounds, their preparation and their use as TACE inhibitors